Hamps Bio
Close ·
Key Fundamentals
SMEConsumer GoodsFMCGPrice-based figures at the close · TTM
- ROCE
- −3.36%
- Debt to Equity
- 0.85
- EPS (TTM)
- —
- Book Value
- ₹9.30
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 2.74
- ROE
- −8.76%
- Dividend Yield
- 0.00%
- EBITDA
- ₹40.00 L
- 52W High
- ₹26.58
- 52W Low
- ₹13.36
Key Insights
Strengths
1- Company's working capital requirements have reduced from 96.6 days to 65.2 days
Weaknesses
3- Stock is trading at 2.64 times its book value
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 4 | 3 | 12 |
| Oscillators | Bearish | 4 | 3 | 2 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bearish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 54.38
- Neutral
- MACD (12,26,9)
- 0.24
- Bullish
- SMA (50)
- 24.78
- Bullish
- SMA (200)
- 23.26
- Bullish
As of
Growth Rate
From the financial statements below. 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 1Y | +26.84% |
|---|
Net profit
| 1Y | Turned to loss |
|---|
Operating cash flow
| 1Y | Outflow narrowed by ₹1.05 Cr |
|---|
Operating margin· change in pp
| 1Y | −11.07 pp |
|---|
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2025 | ₹6.67 Cr |
|---|---|
| Mar 2026 | ₹8.46 Cr |
Net profit by year
| Mar 2025 | ₹0.30 Cr |
|---|---|
| Mar 2026 | −₹0.74 Cr |
Quarterly Results
₹ Cr| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 3.13 | 4.48 |
| Expenses | 2.91 | 4.62 |
| Operating Profit | 0.22 | −0.14 |
| OPM % | 7.03% | −3.12% |
| Other Income | 0.07 | 0.29 |
| Interest | 0.06 | 0.14 |
| Depreciation | 0.19 | 0.51 |
| PBT | 0.04 | −0.5 |
| Tax % | 25% | 6% |
| Net Profit | 0.03 | −0.54 |
| EPS (₹) | 0.03 | −0.62 |
Profit & Loss
₹ Cr| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 6.67 | 8.46 |
| Expenses | 5.9 | 8.42 |
| Operating Profit | 0.77 | 0.04 |
| OPM % | 11.54% | 0.47% |
| Other Income | 0.15 | 0.33 |
| Interest | 0.14 | 0.25 |
| Depreciation | 0.38 | 0.82 |
| PBT | 0.4 | −0.7 |
| Tax % | 25% | 4.29% |
| Net Profit | 0.3 | −0.74 |
| EPS (₹) | 0.34 | −0.85 |
| Div. Payout % | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity Capital | 4.36 | 8.71 |
| Reserves | 4.44 | −0.61 |
| Borrowings | 2.97 | 6.89 |
| Other Liabilities | 1.02 | 0.93 |
| Total Liabilities | 12.79 | 15.92 |
| Fixed Assets | 2.48 | 9.1 |
| CWIP | 3.38 | 1.08 |
| Investments | 0 | 0.07 |
| Other Assets | 6.93 | 5.67 |
| Total Assets | 12.79 | 15.92 |
Cash Flow
₹ Cr| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Operating | −1.76 | −0.71 |
| Investing | −6.21 | −2.93 |
| Financing | 8 | 3.72 |
| Net Cash Flow | 0.04 | 0.07 |
| Free Cash Flow | −5.48 | −5.84 |
| CFO/EBITDA | −214 | −1,775 |
Ratios
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Debtor Days | 65.12 | 68.6 |
| Inventory Days | 434 | 298 |
| Days Payable | 110 | 39.27 |
| Cash Conversion Cycle | 390 | 327 |
| Working Capital Days | 128 | 65.15 |
| ROCE % | — | −3.36% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Hamps Bio insights
55 extracted metrics across FY24–FY26.
Documents
- General announcements 14 Oct 2026
Frequently Asked Questions about Hamps Bio
What does Hamps Bio Limited do?
Where is Hamps Bio Limited (HAMPS) listed?
Which sector does Hamps Bio Limited belong to?
What is the 52-week high and low of Hamps Bio Limited?
What is the Return on Equity (ROE) of Hamps Bio Limited?
Company Information
Incorporated in 2007, Hamps Bio Ltd is in the business of Pharmaceutical Formulation and Freeze-Drying Ingredient Manufacturing and Distribution
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544312.md for Hamps Bio Limited: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.